September 21/Weizmann Technology Park, Israel/Press Release -- Herbamed Ltd. appointed DVA America as its exclusive agent for Ultrasome CoQ10 in the Eastern U.S. and Canada.
Ultrasome is a liposomal-like formulation of Coenzyme Q10 developed by Herbamed using advanced drug-delivery technology. Ultrasome’s unique, patent-protected formulation greatly improves the bioavailability of the CoQ10 by combining ubiquinone with a dual layer of phospholipids to create a small droplet (liposome). This liposome protects the CoQ10 and delivers it more effectively to the g.i. tract, where it is more efficiently absorbed. In a clinical trial, bioavailability was improved by up to 10 times compared to standard forms of the coenzyme.